関連文献

Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease.

Heart Vessels. 30(3): 296-303, 2015.PubMed

Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in Critically Ill Children (AWARE): study protocol for a prospective observational study.

BMC Nephrol. 16(24), 2015.PubMed

Pediatric reference ranges for acute kidney injury biomarkers.

Pediatr Nephrol. 30(4): 677-685, 2015.PubMed

Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.

Am J Physiol Renal Physiol. 308(2): F114-121, 2014.PubMed

Early prediction of acute kidney injury biomarkers after endovascular stent graft repair of aortic aneurysm: a prospective observational study.

J Intensive Care. 2(45), 2014.PubMed

Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 20(12): 2010-2014, 2014.PubMed

A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care.

J Infect Chemother. 21(3): 165-169, 2014.PubMed

Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.

Kidney Int. 87(3): 640-648, 2014.PubMed

Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit.

Nephrol Dial Transplant. 29(1): 73-80, 2014.PubMed

Urinary biomarkers and progression of AKI in patients with cirrhosis.

Clin J Am Soc Nephrol. 9(11): 1857-1867, 2014.PubMed